Pharmafile Logo
Pharmafocus logo
Advanced Search

Barbara Britten, business developement director, Pharmexx UK

pharmafile | October 21, 2009 | Appointment | Sales and Marketing |  appointment, pharmexx, sales and marketing 

Barbara Britten has joined Pharmexx UK as a business developement director.

She most recently worked at Actelion, where she held the position of UK & Ireland sales director.

Barbara has worked in the pharmaceutical industry for 21 years and has held  various senior sales and marketing roles in small through to medium and large sized organisations.

Advertisement

She has a strong heritage in commercialising specialist, niche products and portfolios and will lead the commercial development of the Pharmexx business in the UK.

Related Content

David Wheadon appointed to board of directors at Seaport Therapeutics

This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

sarah_mcdonald

Myeloma UK reveals new Director of Research appointment

UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …

white_and_ford

Abbott CEO to step down after 21 years

After more than two decades at the head of the company, it has emerged that …

The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026